Biochemistry, Genetics and Molecular Biology
Comorbidity
100%
Gene Expression
85%
Gene Expression Profiling
85%
MicroRNA
83%
Cancer Cell
80%
Non-Coding RNA
70%
Klinefelter Syndrome
66%
Metalloprotease Inhibitor
66%
Drug Resistance
66%
Gene Dosage
66%
Indel
64%
Germ Cell
63%
Gonadotropin
50%
Genomics
50%
Messenger RNA
50%
Major Histocompatibility Complex
44%
Haplotype
44%
Y Chromosome
44%
Transcriptome
42%
X Chromosome
41%
Somatic Cell
38%
Genotyping
38%
Single-Nucleotide Polymorphism
36%
Complex System
33%
Morphology
33%
Fulvestrant
33%
Mutation Rate
33%
Tumor Antigen
33%
Progesterone Receptor
33%
Knowledge Base
33%
Protein Interaction
33%
Gene Mapping
33%
Nested Gene
33%
Interactome
33%
Carcinoembryonic Antigen
33%
Transferrin Receptor
33%
Low Drug Dose
33%
Association Mapping
33%
Chromosome Abnormality
33%
X-Inactivation
33%
Human Leukocyte Antigen
33%
Gene Conversion
33%
Regulatory Network
33%
Simian Virus 40
33%
RNA
30%
Pan-Genome
30%
Mosaicism
28%
Long Non-Coding RNA
27%
Human Genome
27%
Down Syndrome
22%
Keyphrases
Comorbidity
66%
Non-coding RNA (ncRNA)
66%
De-novo Assembly
60%
Protein-protein Interaction
56%
Gene Dosage
55%
Structural Variants
50%
Testicle
50%
Indel
46%
MicroRNA
44%
Y Chromosome
41%
Inhibin
41%
Major Histocompatibility Complex
41%
Structural Variation
41%
X Chromosome
40%
Transcriptome Profiling
39%
MCF-7
38%
Population-wide
38%
Gonadotropins
37%
Expression Change
37%
Transcriptome
37%
Danish Population
36%
Overexpression
35%
Adult Testis
34%
Human Breast Cancer Cells
33%
Syntenic Blocks
33%
Gene Conversion
33%
Global Gene Expression Profiling
33%
Human Y Chromosome
33%
Somatic Cells
33%
Mouse Testis
33%
Genetic Aberrations
33%
Colorectal Cancer
33%
Fulvestrant
33%
Mutation Rate
33%
Denmark
33%
Population Scale
33%
Typing Performance
33%
Pathophysiology
33%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
33%
Breast Cancer Cells
33%
Progesterone Receptor Expression
33%
Novel Genes
33%
Corona Radiata
33%
Klinefelter Syndrome
33%
Predictive Signature
33%
Adrenal Tumor
33%
Non-invasive Biomarkers
33%
Specific Genes
33%
Patient Demographics
33%
T Antigen
33%
